📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MolMed

1.1 - Company Overview

MolMed Logo

MolMed

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical biotechnology research, development and clinical validation of novel anticancer therapies. The pipeline includes antitumour therapeutics in clinical and preclinical development, including Zalmoxis (TK), a cell-based therapy enabling bone marrow transplants from partially compatible donors.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MolMed

Intercell Logo

Intercell

HQ: Austria Website
  • Description: Provider of vaccine design and development for prevention and treatment of infectious diseases, leveraging proprietary technology platforms to discover and develop antigens and adjuvants. Founded in 1998 and headquartered in Vienna, Austria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intercell company profile →
Tetherex Pharmaceuticals Logo

Tetherex Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology therapeutics under development, including SelK2, a humanized monoclonal antibody targeting PSGL-1 for asthma and COPD, and SC-Ad6-1, a single-cycle adenovirus vector expressing the SARS-CoV-2 spike protein for intranasal or intramuscular administration to induce mucosal and systemic immunity against COVID-19.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tetherex Pharmaceuticals company profile →
Vaxart Logo

Vaxart

HQ: United States Website
  • Description: Provider of oral vaccine pills and vaccine technology for infectious diseases, including COVID-19 (Phase II, room-temperature stable for easier global distribution), norovirus (Phase 1), influenza (Phase 1 completed for H1N1 and influenza B), RSV (targeting vulnerable populations), and an HPV therapeutic vaccine for types 16 and 18, built on the VAAST™ platform using Ad5 to deliver antigens and adjuvants to mucosal cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vaxart company profile →
BlossomHill Therapeutics Logo

BlossomHill Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies focused on oncology and autoimmune disorders, including FDA-approved repotrectinib (AUGTYRO) for ROS1+ NSCLC, crizotinib (XALKORI) and lorlatinib (LORBRENA), and pipeline candidates elzovantinib (TPX-0022) and TPX-0046, both in Phase 1 studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BlossomHill Therapeutics company profile →
X-Body Biosciences Logo

X-Body Biosciences

HQ: United States Website
  • Description: Provider of biotechnology R&D focused on discovering and developing compounds against therapeutic targets in oncology and ophthalmology, including discovery of human antibodies against high-value targets; engages in alliances with other corporations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full X-Body Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MolMed

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MolMed

2.2 - Growth funds investing in similar companies to MolMed

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MolMed

4.2 - Public trading comparable groups for MolMed

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MolMed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MolMed

What does MolMed do?

MolMed is a provider of medical biotechnology research, development and clinical validation of novel anticancer therapies. The pipeline includes antitumour therapeutics in clinical and preclinical development, including Zalmoxis (TK), a cell-based therapy enabling bone marrow transplants from partially compatible donors.

Who are MolMed's competitors?

MolMed's competitors and similar companies include Intercell, Tetherex Pharmaceuticals, Vaxart, BlossomHill Therapeutics, and X-Body Biosciences.

Where is MolMed headquartered?

MolMed is headquartered in Italy.

How many employees does MolMed have?

MolMed has 1,000 employees 🔒.

When was MolMed founded?

MolMed was founded in 2010 🔒.

What sector and industry vertical is MolMed in?

MolMed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MolMed

Who are the top strategic acquirers in MolMed's sector and industry

Top strategic M&A buyers and acquirers in MolMed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MolMed?

Top strategic M&A buyers groups and sectors for MolMed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MolMed's sector and industry vertical

Which are the top PE firms investing in MolMed's sector and industry vertical?

Top PE firms investing in MolMed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MolMed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MolMed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MolMed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MolMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MolMed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MolMed?

The key public trading comparables and valuation benchmarks for MolMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MolMed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MolMed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MolMed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MolMed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MolMed's' sector and industry vertical?

Access recent funding rounds and capital raises in MolMed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MolMed